How to Reduce Medical Device Test Failures

A device that fails dielectric strength, acoustic output, image quality, or usability validation late in development rarely has a single root cause. More often, the failure began months earlier with an incomplete standards assessment, a prototype that did not represent production intent, or an assumption that a bench result would translate directly to formal compliance testing. To reduce medical device test failures, manufacturers need to treat laboratory evaluation as a controlled extension of design verification, not as a final regulatory checkpoint.

For product development, quality, and regulatory teams, the objective is not simply to obtain a passing report. It is to generate valid, traceable evidence that the device meets its applicable safety and performance requirements under defined test conditions. That distinction changes how teams select standards, prepare samples, define configurations, and respond when results are outside acceptance criteria.

Why Medical Device Tests Fail Late

Late-stage failures commonly arise at the boundary between design intent and test execution. Engineering may have verified a feature internally, while the formal test method applies different loading conditions, environmental conditions, measurement uncertainty, or acceptance criteria. A test laboratory is required to follow the applicable standard and documented protocol. It cannot substitute an informal engineering rationale for an objective requirement.

Electrical safety testing illustrates the issue. A device may power on reliably and pass functional checks, yet fail leakage current or dielectric strength because of component selection, insulation spacing, grounding architecture, accessible metal parts, or an unexpected operating mode. Similarly, an ultrasound system may produce clinically acceptable images during development but fail an acoustic output or image-quality assessment when evaluated using the prescribed transducer, phantom, settings, and measurement method.

Human factors validation can expose another class of failure. The device may function as designed, but the instructions, labeling, alarm behavior, workflow, or user interface may not adequately support safe use by the intended user population. These findings are not cosmetic. They can affect the safety case, risk controls, and regulatory submission strategy.

Build a Test Strategy Before Design Freeze

The most effective way to reduce medical device test failures is to create a standards-based test strategy while the design can still be changed efficiently. This begins with a documented assessment of the device’s intended use, technology, patient contact, energy sources, accessories, environments of use, and markets. Those characteristics drive the standards and test methods that may apply.

A test strategy should identify the relevant general and particular standards, collateral standards, performance standards, and product-specific guidance where applicable. For many electrically powered devices, the evaluation may include elements of IEC 60601-1 and applicable collateral or particular standards. A diagnostic ultrasound system may require specialized acoustic and imaging evaluations. Endoscopes, catheters, ECG equipment, patient monitors, and physiotherapy systems each introduce different performance, materials, electrical, mechanical, and usability considerations.

Standards applicability is not a one-time administrative exercise. It should be revisited when the design changes, new accessories are added, software behavior changes, manufacturing processes shift, or a new intended use is introduced. A change that appears minor from an engineering perspective can alter the worst-case configuration for formal testing.

Define the Test Article and Worst-Case Configuration

A passing result is only useful if the tested article represents the device that will be placed on the market. Teams should define the device under test with the same discipline used for design verification records. Record the model number, hardware revision, software or firmware version, accessories, cables, power supplies, disposables, and relevant manufacturing status.

The most challenging configuration is not always the base model. It may be the longest cable, highest-output setting, largest transducer, lowest supply voltage, maximum patient load, or a combination of accessories that creates the highest leakage current or thermal exposure. For reusable products, the worst case may emerge after specified cleaning, disinfection, sterilization, aging, or repeated-use cycles.

This analysis should be documented before samples are sent to the laboratory. If a test report does not clearly identify the evaluated configuration, regulatory reviewers and internal quality teams may question whether the evidence supports the commercial device.

Use Pre-Compliance Testing With Clear Limits

Pre-compliance testing is a practical risk-reduction tool, especially for new platforms, novel energy delivery systems, or devices nearing design verification. It can identify likely problems in electrical safety, electromagnetic compatibility, acoustic output, thermal behavior, mechanical integrity, or performance before the formal test sequence begins.

However, pre-compliance results should not be treated as interchangeable with accredited testing. Screening may use different equipment, sample preparation, test setups, or controlled conditions. Its value lies in finding issues early and directing design improvements, not in replacing the final evidence package.

The strongest approach is to use pre-compliance work against the same acceptance criteria and operating conditions anticipated for formal testing whenever feasible. If the formal method requires a particular phantom, fixture, measurement location, operating mode, or environmental condition, incorporate it into early engineering testing. This reduces the chance that a device passes an internal surrogate test but fails the required method.

Prepare Samples as Controlled Evidence

Sample readiness is a frequent source of avoidable delays and invalid results. A laboratory needs enough information to configure and operate the device exactly as intended. Missing chargers, incompatible cables, expired disposables, incomplete instructions, unavailable service software, or unclear startup sequences can interrupt testing and introduce unnecessary uncertainty.

Before shipment, conduct a sample readiness review that confirms the following: the device is functional; the hardware and software versions are identified; all required accessories are included; test fixtures and consumables are available; operating instructions are current; and the sample has been inspected for shipping damage. Where products have configurable settings, provide a controlled configuration matrix rather than relying on informal instructions in email.

For products involving materials or patient-contacting components, sample history also matters. Document the material lot, processing method, cleaning status, sterilization status, aging condition, and prior use. A material or component that differs from production intent may produce a result that cannot be used to support the final design.

Align Risk Management, Requirements, and Test Protocols

Formal testing is more efficient when the design inputs, risk management file, verification plan, and protocol all use consistent language. If the risk analysis identifies excessive surface temperature as a hazardous situation, the associated design requirement should define measurable limits, conditions, and acceptance criteria. The test protocol should then evaluate those conditions in a traceable way.

Misalignment creates difficult questions after results are issued. A report may show that the device met a laboratory criterion, while the risk file references a different operating state or acceptance limit. Alternatively, a protocol may omit a foreseeable use condition that the human factors evaluation or complaint history identifies as relevant. Resolving these gaps after testing can require additional samples, protocol amendments, or retesting.

Clear requirements also prevent teams from treating borderline results as administrative problems. Measurement uncertainty, test tolerances, and standard-defined limits must be understood before testing starts. Where a result is close to the limit, engineering should assess design margin rather than assume that a small adjustment to the test setup will resolve the underlying risk.

Manage Changes During the Test Window

Testing programs often run alongside active development. This creates pressure to update firmware, replace components, revise accessories, or modify labeling while samples are already in the laboratory. Some changes are necessary, but uncontrolled changes can invalidate work already completed or make reports difficult to defend.

Establish a change-control process for the test window. Any proposed modification should be evaluated for its effect on completed and planned tests, risk controls, labeling, software documentation, and configuration records. The decision should identify whether the change requires partial retesting, full retesting, or a documented technical rationale.

Communication matters here. Provide the laboratory with a single technical contact who can answer configuration questions promptly and a regulatory or quality contact who can approve protocol decisions. Delays often occur not because a test is technically difficult, but because no one is authorized to confirm the intended operating mode or provide the required documentation.

Investigate Failures Scientifically

A failed result should trigger a structured investigation, not an immediate retest request. First, confirm the test article identity, setup, instrumentation, operating state, and applicable acceptance criteria. Then determine whether the result reflects a device defect, a sample-specific anomaly, a configuration issue, an unclear requirement, or a potential test execution concern.

If the device requires redesign, assess the impact beyond the failed clause. An insulation change can affect materials, manufacturing, thermal performance, and electrical safety. A software adjustment to an alarm may affect usability, cybersecurity documentation, and system-level performance. Corrective action should address the root cause and define objective evidence that the correction is effective.

Retesting should be targeted and justified. Repeating a test without changing the condition that caused failure wastes samples and schedule. In contrast, a well-documented investigation can define the exact retest scope and preserve the credibility of the overall verification record.

Select Laboratory Support That Matches the Device

Specialized devices benefit from a laboratory that understands the applicable test methods and the regulatory significance of the resulting data. Accreditation scope, equipment capability, personnel expertise, protocol control, and reporting quality should be evaluated alongside schedule. A fast start is valuable only when the testing plan is technically sound and the final documentation is suitable for its intended regulatory use.

Sigma Scientific Services supports medical device manufacturers with standards-based safety and performance testing across electrical, acoustic, ultrasound, materials, endoscope, physiotherapy, clinical, and human factors evaluation areas. Early technical alignment on scope, samples, configurations, and documentation can prevent avoidable testing cycles before they affect submission timing.

The most reliable test program is built when engineering, quality, regulatory affairs, and the laboratory agree on the same question before the first measurement is taken: what exact device, under what conditions, must demonstrate which requirement? Answer that precisely, and formal testing becomes evidence of readiness rather than a late discovery process.